International Journal of Molecular Medical Science, 2025, Vol.15, No.4, 165-174 http://medscipublisher.com/index.php/ijmms 171 6.2 Large-scale multi-hospital studies specifically targeting frail elderly people More and more people have come to realize that large-scale clinical trials need to be conducted simultaneously in many hospitals, and these trials should specifically include elderly people who are physically weak and have weakened immune systems. This kind of research is of great significance because it can capture the huge differences in the physical and immune responses of this group of people, and also test the effectiveness of predictive models and biomarkers in different places. The methods and research designs of unified immunization tests are also crucial, so as to ensure that the results of different studies can be compared and replicated, and ultimately provide reliable evidence for how to best vaccinate frail elderly people (Goudsmit et al., 2021). Conducting research in many hospitals can also involve people from different regions and with different genetic backgrounds. In this way, researchers can take into account factors such as the environment, lifestyle and genetic genes that affect the efficacy of vaccines. These large-scale studies have sufficient "statistical power" to discover differences among various small populations (subgroups) and can also test customized vaccine approaches in real frail elderly people, such as changing dosages or using different booters (Goudsmit et al., 2021). 6.3 Predicting vaccine responses with new technologies The combination of techniques that study various parts of the immune system (immunomics) and disciplines that observe overall changes in the body (systems biology) is greatly transforming our ability to predict vaccine responses. With the help of technologies that can simultaneously measure multiple indicators-such as viewing gene activity, protein status and analyzing individual immune cells-combined with computer analysis, a complete state map of the immune system before and after vaccination can be drawn. This "systematic vaccinology" approach can identify which molecules and cells can predict vaccine efficacy, discover new biomarkers, and understand why some frail elderly people have a poor response to vaccines (Tsang et al., 2020; Van Tilbeurgh et al., 2021; Hou and Nakaya, 2024). When these research techniques of all parts are combined with machine learning, predictive models can be developed and verified in the laboratory and on patients. The ultimate goal is to utilize these findings to design the next generation of better vaccines and individualized vaccination plans, providing maximum protection for frail elderly people (Tsang et al., 2020; Van Tilbeurgh et al., 2021; Hou and Nakaya, 2024). 7 Concluding Remarks The effectiveness of vaccination for physically weak elderly people is influenced by multiple factors, including their own physical condition and the state of their immune system. Key physical factors include age, whether there are other chronic diseases, good nutrition and lifestyle habits (such as exercise and sleep), all of which can affect the antibodies and immune cell responses produced by the body after vaccination. From the perspective of the immune system, the changes brought about by aging, such as the aging of the immune system, long-term mild inflammation in the body, and the different genes of each person, can all reduce the effectiveness of vaccines, and the responses of each person also vary greatly. These circumstances indicate that we need to study more carefully how internal factors and external environments of the body affect the efficacy of vaccines for this vulnerable group. To make physically weak elderly people more willing to get vaccinated and ensure better vaccine outcomes, it is necessary to come up with solutions from multiple aspects together. There is evidence that the combined use of some measures is very effective, such as training medical staff, reminding patients to get vaccinated, making vaccination more convenient, and providing economic subsidies - all of which can solve the difficulties and concerns in actual vaccination. A new direction called "personalized vaccinology", which utilizes genetic information, the technology of studying the entire immune system (immunomics), and the science of observing overall changes in the body (systems biology), holds great promise. It can select the appropriate type, dosage and injection time of vaccines based on each person's risk situation, which can not only improve the effect but also ensure safety. Specific approaches may include adjusting the vaccine formula, using booster shots (adjuvants), or changing the vaccination plan based on the immune status and predictive markers.
RkJQdWJsaXNoZXIy MjQ4ODYzNA==